Dr. Reddy's Labs Files Routine 6-K Disclosure
Ticker: RDY · Form: 6-K · Filed: Sep 8, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-disclosure, foreign-private-issuer
TL;DR
DRL filed a 6-K, just a routine check-in, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 8, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is required to file annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating ongoing compliance with SEC reporting requirements rather than announcing new business developments.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure for a foreign private issuer and does not contain material non-public information that would typically impact stock price.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000562 (filing_id) — Accession Number
- 20250908 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information required by Section 13(a) or 15(d) of the Securities Exchange Act of 1934 by a foreign private issuer, such as Dr. Reddy's Laboratories Ltd.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on September 8, 2025.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
Where is Dr. Reddy's Laboratories Ltd. principal executive office located?
The principal executive office of Dr. Reddy's Laboratories Ltd. is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Is Dr. Reddy's Laboratories Ltd. submitting this Form 6-K in paper format?
The filing does not explicitly state whether it is submitted in paper format, but it does not check the box indicating submission as permitted by Regulation S-T Rule 101(b)(1).
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-09-08 08:07:30
Filing Documents
- rdy0800_6k.htm (6-K) — 53KB
- rdy0800_ex99-1.htm (EX-99.1) — 25KB
- rdy0800_ex99-1img01.jpg (GRAPHIC) — 11KB
- rdy0800_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-25-000562.txt ( ) — 106KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: September 6, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3